Billionaire George Soros showed interest in large banks and cloud computing companies in the second quarter, according to a submission to the Securities and Exchange Commission. In the quarter ended June 30, Soros Fund Management added a new 1.2 million stake in Bank of America Corp. BAC, + 0.45%, a …
Read More »Stifel cuts COVID-19 fax developer Inovio’s price target as revenue and calls more questions than answers
Stifle analysts cut their share price target for Inovio Pharmaceuticals Inc. INO, -6.08% to $ 16 from $ 24 on Tuesday, after the company posted a broader-than-expected second-quarter loss and revenue that fell short of estimate. Inovio is one of many companies working on developing a COVID-19 vaccine candidate. The …
Read More »Inovio Pharma share fluctuates after results, fax update
Inovio Pharmaceuticals Inc. INO, -6.08% shares fluctuated between light gains and losses in the extended session Monday after the biotech company reported results that were short of Wall Street estimates while updating on its COVID-19 vaccine. Inovio shares were up 0.6% after hours last, after a 6.1% decline in the …
Read More »FDA issues rules for developers of coronavirus vaccines
The Food and Drug Administration (FDA) issued new rules Tuesday for companies developing COVID-19 vaccines. “While the FDA is committed to helping expedite this work, we are not going to cut corners in our decision making, and we are clarifying in our guidance what data we need, which needs to …
Read More »Inovio shares rise to extend rally to 20-year high, while Stifel says price is now ‘less palatable’
Shares of Inovio Pharmaceuticals Inc. INO, -9.79% 7.5% was recovered in premarket operations on Friday, to extend its recent rocket launch to a maximum of 20 years, even as the biotech company was downgraded in Stifel Nicolaus over valuation concerns. The stock is up 119% amid a four-day streak to …
Read More »